Tuesday, January 9, 2007
The next Vioxx trial in New Jersey is scheduled to begin January 22. It's a consolidated trial of four cases, the most significant trial aggregation to date. The court posted on its website a Vioxx Trial Information sheet explaining the phased trial. The first phase will be a consolidated trial "on issues of what Merck knew about the risk of Vioxx; what warnings they gave the physicians; whether the warnings were adequate." If the jury's special verdict at the end of this phase is in Merck's favor, then the case is over. If in plaintiffs' favor, then the trial moves to a second phase of separate, individual trials (before the same jury) on individual causation and damages.